Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan Williams

Showing results (241-250 of 417) with videos related to

Pageof 42
Sort By:
European Journal of Heart Failure|March 30, 2023
Deep phenotype characterization of hypertensive response to exercise: implications on functional capacity and prognosis across the heart failure spectrumNicola Riccardo Pugliese, Nicolò De Biase, Lavinia Del Punta, et al.
Diabetes Care|October 4, 2013
The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients with type 2 diabetesGraham S Hillis, Paul Welsh, John Chalmers, et al.
Cardiovascular Research|December 11, 2021
Contributions of obesity to kidney health and disease: insights from Mendelian randomization and the human kidney transcriptomicsXiaoguang Xu, James M Eales, Xiao Jiang, et al.
Hypertension (Dallas, Tex. : 1979)|June 15, 2023
Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINEFelix Mahfoud, Giuseppe Mancia, Roland E Schmieder, et al.
Diabetologia|July 15, 2019
The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON studyMegumi Oshima, Min Jun, Toshiaki Ohkuma, et al.
Lancet (London, England)|September 29, 2015
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trialBryan Williams, Thomas M MacDonald, Steve Morant, et al.
JACC. Cardiovascular Imaging|September 8, 2022
Ventricular-Arterial Coupling Derived From Proximal Aortic Stiffness and Aerobic Capacity Across the Heart Failure SpectrumNicola Riccardo Pugliese, Alessio Balletti, Silvia Armenia, et al.
Hypertension (Dallas, Tex. : 1979)|May 7, 2020
2020 International Society of Hypertension Global Hypertension Practice GuidelinesThomas Unger, Claudio Borghi, Fadi Charchar, et al.
Diabetes Care|July 8, 2017
Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE TrialToshiaki Ohkuma, Min Jun, Mark Woodward, et al.
Hypertension (Dallas, Tex. : 1979)|February 19, 2015
First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertensionMichael Böhm, Felix Mahfoud, Christian Ukena, et al.
Pageof 42

Showing results (241-250 of 417) with videos related to

Sort By:
Pageof 42
European Journal of Heart Failure|March 30, 2023
Deep phenotype characterization of hypertensive response to exercise: implications on functional capacity and prognosis across the heart failure spectrumNicola Riccardo Pugliese, Nicolò De Biase, Lavinia Del Punta, et al.
Diabetes Care|October 4, 2013
The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients with type 2 diabetesGraham S Hillis, Paul Welsh, John Chalmers, et al.
Cardiovascular Research|December 11, 2021
Contributions of obesity to kidney health and disease: insights from Mendelian randomization and the human kidney transcriptomicsXiaoguang Xu, James M Eales, Xiao Jiang, et al.
Hypertension (Dallas, Tex. : 1979)|June 15, 2023
Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINEFelix Mahfoud, Giuseppe Mancia, Roland E Schmieder, et al.
Diabetologia|July 15, 2019
The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON studyMegumi Oshima, Min Jun, Toshiaki Ohkuma, et al.
Lancet (London, England)|September 29, 2015
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trialBryan Williams, Thomas M MacDonald, Steve Morant, et al.
JACC. Cardiovascular Imaging|September 8, 2022
Ventricular-Arterial Coupling Derived From Proximal Aortic Stiffness and Aerobic Capacity Across the Heart Failure SpectrumNicola Riccardo Pugliese, Alessio Balletti, Silvia Armenia, et al.
Hypertension (Dallas, Tex. : 1979)|May 7, 2020
2020 International Society of Hypertension Global Hypertension Practice GuidelinesThomas Unger, Claudio Borghi, Fadi Charchar, et al.
Diabetes Care|July 8, 2017
Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE TrialToshiaki Ohkuma, Min Jun, Mark Woodward, et al.
Hypertension (Dallas, Tex. : 1979)|February 19, 2015
First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertensionMichael Böhm, Felix Mahfoud, Christian Ukena, et al.
Pageof 42